Early stage medical device developer Tulavi Therapeutics has raised approximately $3 million in a new round of equity financing, according to recently posted SEC filings. Tulavi Therapeutics is developing a medical device-based therapy intended to prevent or treat aberrant neural reflex arcs in peripheral and visceral disease. The technology is intended for use through both […]